{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:55:24Z","timestamp":1756572924809},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Imaging and Behavior"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11682-023-00789-z","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T03:21:53Z","timestamp":1689909713000},"page":"619-627","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["[18F]-FDopa positron emission tomography imaging in corticobasal syndrome"],"prefix":"10.1007","volume":"17","author":[{"given":"Ana\u00efs","family":"El Ouartassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Giordana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Schiazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Chardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Darcourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"789_CR1","doi-asserted-by":"crossref","unstructured":"Alster, P., Madetko, N. K., Koziorowski, D. M., Kr\u00f3licki, L., Budrewicz, S., Friedman, A. (2019) Accumulation of Tau protein, metabolism and perfusion\u2014application and efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) imaging in the examination of Progressive Supranuclear Palsy (PSP) and corticobasal. Frontiers in Neurology. 10.","DOI":"10.3389\/fneur.2019.00101"},{"issue":"5","key":"789_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., et al. (2013). Criteria for the diagnosis of corticobasal degeneration. Neurology, 80(5), 496\u2013503.","journal-title":"Neurology"},{"issue":"1","key":"789_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3233\/JAD-190961","volume":"74","author":"A Benvenutto","year":"2020","unstructured":"Benvenutto, A., Guedj, E., Felician, O., Eusebio, A., Azulay, J. P., Ceccaldi, M., et al. (2020). Clinical phenotypes in corticobasal syndrome with or without amyloidosis biomarkers. Journal of Alzheimer\u2019s Disease, 74(1), 331\u2013343.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"4","key":"789_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/archneur.1991.00530160057013","volume":"48","author":"MH Bhatt","year":"1991","unstructured":"Bhatt, M. H., Snow, B. J., Martin, W. R., Peppard, R., & Calne, D. B. (1991). Positron emission tomography in progressive supranuclear palsy. Archives of Neurology, 48(4), 389\u2013391.","journal-title":"Archives of Neurology"},{"issue":"4","key":"789_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1212\/WNL.53.4.795","volume":"53","author":"BF Boeve","year":"1999","unstructured":"Boeve, B. F., Maraganore, D. M., Parisi, J. E., Ahlskog, J. E., Graff-Radford, N., Caselli, R. J., et al. (1999). Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology, 53(4), 795\u2013800.","journal-title":"Neurology"},{"issue":"4","key":"789_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ana.410280412","volume":"28","author":"DJ Brooks","year":"1990","unstructured":"Brooks, D. J., Ibanez, V., Sawle, G. V., Quinn, N., Lees, A. J., Mathias, C. J., et al. (1990). Differing patterns of striatal18F-dopa uptake in Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy. Annals of Neurology., 28(4), 547\u2013555.","journal-title":"Annals of Neurology."},{"issue":"2","key":"789_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3233\/JAD-200153","volume":"76","author":"C Cerami","year":"2020","unstructured":"Cerami, C., Dodich, A., Iannaccone, S., Magnani, G., Marcone, A., Guglielmo, P., et al. (2020). Individual brain metabolic signatures in corticobasal syndrome. Journal of Alzheimer\u2019s Disease, 76(2), 517\u2013528.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"5","key":"789_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.parkreldis.2013.01.013","volume":"19","author":"R Ceravolo","year":"2013","unstructured":"Ceravolo, R., Rossi, C., Cilia, R., Tognoni, G., Antonini, A., Volterrani, D., et al. (2013). Evidence of delayed nigrostriatal dysfunction in corticobasal syndrome: A SPECT follow-up study. Parkinsonism & Related Disorders, 19(5), 557\u2013559.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"789_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018301","volume":"6","author":"R Cilia","year":"2011","unstructured":"Cilia, R., Rossi, C., Frosini, D., Volterrani, D., Siri, C., Pagni, C., et al. (2011). Dopamine transporter SPECT imaging in corticobasal syndrome. PLoS One, 6(5), e18301.","journal-title":"PLoS One"},{"issue":"2","key":"789_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00259-009-1267-x","volume":"37","author":"J Darcourt","year":"2010","unstructured":"Darcourt, J., Booij, J., Tatsch, K., Varrone, A., Vander Borght, T., Kapucu, \u00d6. L., et al. (2010). EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. European Journal of Nuclear Medicine and Molecular Imaging, 37(2), 443\u2013450.","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"4","key":"789_CR11","first-page":"355","volume":"58","author":"J Darcourt","year":"2014","unstructured":"Darcourt, J., Schiazza, A., Sapin, N., Dufour, M., Ouvrier, M. J., Benisvy, D., et al. (2014). 18F-FDOPA PET for the diagnosis of parkinsonian syndromes. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 58(4), 355\u2013365.","journal-title":"The Quarterly Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"5","key":"789_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/ene.13928","volume":"26","author":"F Di Stasio","year":"2019","unstructured":"Di Stasio, F., Suppa, A., Marsili, L., Upadhyay, N., Asci, F., Bologna, M., et al. (2019). Corticobasal syndrome: Neuroimaging and neurophysiological advances. European Journal of Neurology., 26(5), 701.","journal-title":"European Journal of Neurology."},{"issue":"1","key":"789_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0022-510X(03)00232-6","volume":"216","author":"M Doran","year":"2003","unstructured":"Doran, M., du Plessis, D. G., Enevoldson, T. P., Fletcher, N. A., Ghadiali, E., & Larner, A. J. (2003). Pathological heterogeneity of clinically diagnosed corticobasal degeneration. Journal of the Neurological Sciences, 216(1), 127\u2013134.","journal-title":"Journal of the Neurological Sciences"},{"issue":"5\u20136","key":"789_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000443667","volume":"16","author":"S Hammesfahr","year":"2016","unstructured":"Hammesfahr, S., Antke, C., Mamlins, E., Beu, M., Wojtecki, L., Ferrea, S., et al. (2016). FP-CIT- and IBZM-SPECT in corticobasal syndrome: results from a clinical follow-up study. Neuro-Degenerative Diseases, 16(5\u20136), 342\u2013347.","journal-title":"Neuro-Degenerative Diseases"},{"issue":"6","key":"789_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Movement Disorders, 32(6), 853\u2013864.","journal-title":"Movement Disorders"},{"issue":"5","key":"789_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/MNM.0b013e32835fcd7f","volume":"34","author":"A Jaimini","year":"2013","unstructured":"Jaimini, A., Tripathi, M., D\u2019Souza, M. M., Panwar, P., Sharma, R., Mehta, S., et al. (2013). Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson\u2019s disease from atypical parkinsonian disorders. Nuclear Medicine Communications, 34(5), 426\u2013431.","journal-title":"Nuclear Medicine Communications"},{"issue":"5","key":"789_CR17","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s00415-013-6886-2","volume":"260","author":"V Kaasinen","year":"2013","unstructured":"Kaasinen, V., Gardberg, M., R\u00f6ytt\u00e4, M., Sepp\u00e4nen, M., & P\u00e4iv\u00e4rinta, M. (2013). Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration. Journal of Neurology, 260(5), 1410\u20131411.","journal-title":"Journal of Neurology"},{"issue":"10","key":"789_CR18","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/mds.21004","volume":"21","author":"S Klaffke","year":"2006","unstructured":"Klaffke, S., Kuhn, A. A., Plotkin, M., Amthauer, H., Harnack, D., Felix, R., et al. (2006). Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration. Movement Disorders, 21(10), 1724\u20131727.","journal-title":"Movement Disorders"},{"issue":"9","key":"789_CR19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/jnnp-2021-328586","volume":"93","author":"S Koga","year":"2022","unstructured":"Koga, S., Josephs, K. A., Aiba, I., Yoshida, M., & Dickson, D. W. (2022). Neuropathology and emerging biomarkers in corticobasal syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 93(9), 919\u2013929.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"12","key":"789_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s004150050534","volume":"246","author":"S Laureys","year":"1999","unstructured":"Laureys, S., Salmon, E., Garraux, G., Peigneux, P., Lemaire, C., Degueldre, C., et al. (1999). Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. Journal of Neurology, 246(12), 1151\u20131158.","journal-title":"Journal of Neurology"},{"issue":"2","key":"789_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ana.22424","volume":"70","author":"SE Lee","year":"2011","unstructured":"Lee, S. E., Rabinovici, G. D., Mayo, M. C., Wilson, S. M., Seeley, W. W., DeArmond, S. J., et al. (2011). Clinicopathological correlations in corticobasal degeneration. Annals of Neurology, 70(2), 327\u2013340.","journal-title":"Annals of Neurology"},{"issue":"1","key":"789_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1212\/WNL.48.1.119","volume":"48","author":"I Litvan","year":"1997","unstructured":"Litvan, I., Agid, Y., Goetz, C., Jankovic, J., Wenning, G. K., Brandel, J. P., et al. (1997). Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study. Neurology, 48(1), 119\u2013125.","journal-title":"Neurology"},{"issue":"2","key":"789_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/jon.12391","volume":"27","author":"E Mille","year":"2017","unstructured":"Mille, E., Levin, J., Brendel, M., Zach, C., Barthel, H., Sabri, O., et al. (2017). Cerebral glucose metabolism and dopaminergic function in patients with corticobasal syndrome. Journal of Neuroimaging, 27(2), 255\u2013261.","journal-title":"Journal of Neuroimaging"},{"issue":"8","key":"789_CR24","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","volume":"47","author":"S Morbelli","year":"2020","unstructured":"Morbelli, S., Esposito, G., Arbizu, J., Barthel, H., Boellaard, R., Bohnen, N. I., et al. (2020). EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 10. European Journal of Nuclear Medicine and Molecular Imaging, 47(8), 1885\u2013912.","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"2","key":"789_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/0022-510X(96)00057-3","volume":"139","author":"H Nagasawa","year":"1996","unstructured":"Nagasawa, H., Tanji, H., Nomura, H., Saito, H., Itoyama, Y., Kimura, I., et al. (1996). PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration. Journal of the Neurological Sciences, 139(2), 210\u2013217.","journal-title":"Journal of the Neurological Sciences"},{"issue":"11","key":"789_CR26","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1093\/brain\/awu256","volume":"137","author":"M Niethammer","year":"2014","unstructured":"Niethammer, M., Tang, C. C., Feigin, A., Allen, P. J., Heinen, L., Hellwig, S., et al. (2014). A disease-specific metabolic brain network associated with corticobasal degeneration. Brain, 137(11), 3036\u20133046.","journal-title":"Brain"},{"issue":"16","key":"789_CR27","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1002\/mds.22323","volume":"23","author":"SS O'Sullivan","year":"2008","unstructured":"O\u2019Sullivan, S. S., Burn, D. J., Holton, J. L., & Lees, A. J. (2008). Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration. Movement Disorders, 23(16), 2424\u20132426.","journal-title":"Movement Disorders"},{"issue":"1","key":"789_CR28","first-page":"30","volume":"39","author":"M Otsuka","year":"1999","unstructured":"Otsuka, M., & Taniwaki, T. (1999). Functional imaging for disorders of basal ganglia. Rinsho Shinkeigaku, 39(1), 30\u201332.","journal-title":"Rinsho Shinkeigaku"},{"issue":"10","key":"789_CR29","doi-asserted-by":"publisher","first-page":"e1121","DOI":"10.1212\/WNL.0000000000007038","volume":"92","author":"M Pardini","year":"2019","unstructured":"Pardini, M., Huey, E. D., Spina, S., Kreisl, W. C., Morbelli, S., Wassermann, E. M., et al. (2019). FDG-PET patterns associated with underlying pathology in corticobasal syndrome. Neurology, 92(10), e1121\u2013e1135.","journal-title":"Neurology"},{"issue":"3","key":"789_CR30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/mds.28373","volume":"36","author":"JB Parmera","year":"2021","unstructured":"Parmera, J. B., Coutinho, A. M., Aranha, M. R., Studart-Neto, A., de Godoi, C. C., de Almeida, I. J., Fontoura Solla, D. J., Ono, C. R., Barbosa, E. R., Nitrini, R., Buchpiguel, C. A., & Brucki, S. M. D. (2021). FDG-PET patterns predict amyloid deposition and clinical profile in corticobasal syndrome. Movement Disorders, 36(3), 651\u2013661.","journal-title":"Movement Disorders"},{"issue":"7","key":"789_CR31","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.bbadis.2008.10.003","volume":"1792","author":"N Pavese","year":"2009","unstructured":"Pavese, N., & Brooks, D. J. (2009). Imaging neurodegeneration in Parkinson\u2019s disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1792(7), 722\u20139.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"12","key":"789_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., Halliday, G., Goetz, C. G., Gasser, T., Dubois, B., Chan, P., Bloem, B. R., Adler, C. H., & Deuschl, G. (2015). MDS clinical diagnostic criteria for Parkinson\u2019s disease. Movement Disorders, 30(12), 1591\u20131601.","journal-title":"Movement Disorders"},{"issue":"3","key":"789_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0212-6982(09)71352-7","volume":"28","author":"J Pu\u00f1al-Riob\u00f3o","year":"2009","unstructured":"Pu\u00f1al-Riob\u00f3o, J., Serena-Puig, A., Varela-Lema, L., Alvarez-P\u00e1ez, A., & Ruano-Ravina, A. (2009). Utilidad cl\u00ednica de la (18)FDOPA-PET en trastornos del movimiento. Una revisi\u00f3n sistem\u00e1tica [Clinical utility of (18)F-DOPA-PET in movement disorders. A systematic review]. Revista Espa\u00f1ola de Medicina Nuclear, 28(3), 106\u201313.","journal-title":"Revista Espa\u00f1ola de Medicina Nuclear"},{"issue":"Pt 1B","key":"789_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/brain\/114.1.541","volume":"114","author":"GV Sawle","year":"1991","unstructured":"Sawle, G. V., Brooks, D. J., Marsden, C. D., & Frackowiak, R. S. (1991). Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain, 114(Pt 1B), 541\u201356.","journal-title":"Brain"},{"key":"789_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102161","volume":"25","author":"GN Stormezand","year":"2020","unstructured":"Stormezand, G. N., Chaves, L. T., V\u00e1llez Garc\u00eda, D., Doorduin, J., De Jong, B. M., Leenders, K. L., et al. (2020). Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders. NeuroImage: Clinical, 25, 102161.","journal-title":"NeuroImage: Clinical"},{"issue":"1","key":"789_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., et al. (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage, 15(1), 273\u2013289.","journal-title":"NeuroImage"}],"container-title":["Brain Imaging and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11682-023-00789-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11682-023-00789-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11682-023-00789-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T07:13:37Z","timestamp":1703056417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11682-023-00789-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1007\/s11682-023-00789-z","relation":{},"ISSN":["1931-7557","1931-7565"],"issn-type":[{"value":"1931-7557","type":"print"},{"value":"1931-7565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"30 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was declared in the public directory of the Institut National des Donn\u00e9es de Sant\u00e9 (INDS\u2014France) (MR3310220420). The study was approved by the Institutional Review Board of the French Society of Nuclear Medicine Ethic Committee (IRB number: CEMEN 2021\u201304).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Participants\u2019 consents were obtained according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/publication"}},{"value":"We have no conflicts of interest concerning this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}